Drug utilization study on pediatric pneumonia patients in a tertiary care teaching hospital

Ashmi  SK; Hafeeza Y

doi:10.46795/ijhcbs.v2i4.249

Ashmi SK Department of Pharmacy Practice, QIS College of Pharmacy, Ongole, Prakasam District, AP, India-523272
Hafeeza Y Department of Pharmacy Practice, QIS College of Pharmacy, Ongole, Prakasam District, AP, India-523272

DOI https://doi.org/10.46795/ijhcbs.v2i4.249

Abstract

Background: Pneumonia remains the prime infectious disease that increases the mortality rate among children under five claimed the lives of nearly 1.5 million children in 2015. Mortality due to childhood pneumonia is linked to the prevalence and relapse increases and usage of antibiotics is more. In such circumstances, the main.

Aim: The Aim of the study was to assess the utilization of drugs and to spot the factors that contribute to the pediatric pneumonia patients at tertiary care teaching hospitals.

Material and methods: A prospective, observational study was conducted from May 2021 to October 2021Overall 310 prescriptions were collected, 204 patients were included in the study based on inclusion criteria and data was collected from a proforma and by using WHO prescribing indicators study is analyzed.

Results: Age group with pneumonia of<5years was 171 patients, followed by 33 patients between 6-8years.The male children constituted the major portion i.e. 120(58.82%) followed by female children were 84(41.18%). Distribution of drugs per prescription, majority of prescriptions with<5 drugs i.e., 110(56%) followed by 82 prescriptions with 5-10 drugs constituted (43%), this indicates the polypharmacy and 1 prescription with >10 drugs i.e., (1%). The distribution of antibiotics where majorly preferred drug in penicillin’s were amoxiclav- 164(59.20%), least preferred was piperacillin/tazobactam-9(3.28%), followed by cefotaxime-38(13.71%), ceftriaxone -17(6.13%), amikacin- 31(11.19%), and azithromycin- 18(6.49%).

Conclusion: In our study, we observed an irrational use of antibiotics and polypharmacy of drugs in the treatment of pediatric pneumonia.

Keywords: Pneumonia, Drug utilization study, WHO prescribing indicators

Downloads

Download data is not yet available.

References

1. Kelsey D J Jones and James A Berkley.Severe acute malnutrition and infection. Pediatric Int Child Health. 2014; 34(1): 1–29.
2. McCracken GH. Etiology and treatment of pneumonia. Pediatric Infect Dis J 2000; 19:373–377.
3. Richard Ofori-Asensio and Akosua Adam Agyeman.Irrational Use of Medicines—A Summary of Key Concepts. Pharmacy (Basel). 2016 Dec; 4(4): 35.
4. Antenen Assefa Desalegn. Assessment of drug use pattern using WHO prescribing indicators at Hawassa University teaching and referral hospital, south Ethiopia: a cross-sectional study.BMC Health Serv Res. 2013; 13: 170.
5. M.N.G. Dukes, Drug utilization studies methods and uses, WHO regional publications European series no.45.
6. MaximillianMuench off and Philip J.R. Goulder et al., sex differences in pediatric infectious diseases, 2014:2019
7. Dr. Shiva Leela, Dr. Jagadeesh, Dr. Srinivas. Revankar, Dr Vedavathi H,Dr.S. Nagaraja.Prasad, Dr Chidanand K N , Dr Jean L M et al., A Study of Prescription Pattern of Antibiotics in Pediatric In-Patients of Mc-Gann Teaching Hospital Shivamogga Institute of Medical Sciences (SIMS), Shivamogga, Karnataka, Journal of Dental and Medical Sciences,Dec,2014,Vol-13(12).
8. Anandhasayanam Aravamuthan, Mohan Valli Arputhavanan, Kannan Subramaniam and Sam Johnson Udaya Chander J.et al., Assessment of current prescribing practices using World Health Organization core drug use and complementary indicators in selected rural community pharmacies in Southern India, Journal of Pharmaceutical Policy and Practice (2017) 10:1.
9. Rohit C Agrawal. Pneumonia. A Parthasarathy (ed). IAP Textbook of Pediatrics, 5th ed. IAP National Publication House, Gwalior: Jaypee Brothers Medical Publishers; 2013. pp. 489.